High Resolution Retinal Imaging

Launched by UNIVERSITY OF PENNSYLVANIA · May 30, 2013

Keywords

ClinConnect Summary

This clinical trial is focused on using a special imaging technique called adaptive optics scanning laser ophthalmoscope (AOSLO) to take detailed pictures of the retina, which is the light-sensitive layer at the back of the eye. Researchers want to learn more about how the retina looks and functions in both healthy individuals and those with certain eye diseases, like Stargardt's disease, retinitis pigmentosa, age-related macular degeneration, choroideremia, and geographic atrophy. By comparing images from people with and without these conditions, the study aims to improve how we detect and treat retinal diseases.

To join this study, participants need to be at least 7 years old, and if they are under 18, they will need permission from a parent or guardian. The study team will make sure that participants can follow the imaging procedures comfortably. Individuals with certain eye conditions or those who are sensitive to bright lights may not be eligible. During the trial, participants can expect to undergo retinal imaging, which is a non-invasive process that doesn’t hurt. This research is important for advancing our understanding of retinal diseases and could lead to better diagnosis and treatment options in the future.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Males or females age 7 years or older.
• • Parental/guardian permission (informed consent) and if appropriate, child assent. Child subjects age 7-17 must give assent.
• • Reasonable compliance with an imaging protocol as determined by the study personnel.
• Exclusion Criteria:
• • Individuals that are at risk to acute glaucoma.
• • Individuals that are photophobic and experience adverse psychological reactions to flashes of light.
• • Ocular opacities, high refractive error, and high frequency of nystagmus as determined by the study team.